Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis
Author:
Funder
Cystic Fibrosis in Australia
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference45 articles.
1. Physiological levels of lipoxin A4 inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium;Al-Alawi;Physiol. Rep.,2014
2. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology;Altman;Drugs,2015
3. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma;Brocklebank;BMJ (Clinical research ed.),2001
4. Lipoxin A(4)-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair, American journal of physiology;Buchanan;Lung Cell. Mol. Physiol.,2013
5. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy;Cantin;J. Cystic Fibrosis : Off. J. Eur. Cystic Fibrosis Soc.,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology;Biosciences Biotechnology Research Asia;2023-06-30
2. The development of a 3D-printed in vitro integrated oro-pharyngeal air–liquid interface cellular throat model for drug transport;Drug Delivery and Translational Research;2023-02-14
3. Development of Inhalable Spray Dried Nitrofurantoin Formulations for the Treatment of Emphysema;Pharmaceutics;2022-12-31
4. Development and characterization of nanodispersion-based sildenafil pressurized metered-dose inhaler using combined small-angle X-ray scattering, dynamic light scattering, and impactors;Journal of Drug Delivery Science and Technology;2022-10
5. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles;International Journal of Pharmaceutics;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3